Search company, investor...

Predict your next investment

Investments

2

Portfolio Exits

2

About Hanzepoort

Headquarters Location

Want to inform investors similar to Hanzepoort about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Hanzepoort Investments

2 Investments

Hanzepoort has made 2 investments. Their latest investment was in Lanthio Pharma as part of their Series A on November 11, 2012.

CBI Logo

Hanzepoort Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

11/27/2012

Series A

Lanthio Pharma

$6.2M

Yes

1

2/19/2010

Unattributed VC - II

Subscribe to see more

Subscribe to see more

10

Date

11/27/2012

2/19/2010

Round

Series A

Unattributed VC - II

Company

Lanthio Pharma

Subscribe to see more

Amount

$6.2M

New?

Yes

Subscribe to see more

Co-Investors

Sources

1

10

Hanzepoort Portfolio Exits

2 Portfolio Exits

Hanzepoort has 2 portfolio exits. Their latest portfolio exit was Organ Assist on September 28, 2020.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

9/28/2020

Acquired

$99M

1

5/7/2015

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/28/2020

5/7/2015

Exit

Acquired

Acquired

Companies

Subscribe to see more

Valuation

$99M

$99M

Acquirer

Subscribe to see more

Sources

1

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.